血浆脑源性Tau蛋白在大血管闭塞性缺血性卒中预后中的作用
本研究基于两个时间独立的前瞻性队列,纳入前循环大血管闭塞急性缺血性卒中且血管内治疗后成功再通的患者,评估血浆脑源性Tau蛋白(BD-Tau)预测90天功能结局的性能。推导队列(n=78)中,入院BD-Tau对90天功能结局的曲线下面积为0.76(95%CI 0.65-0.87;P<0.001),结合年龄、入院BD-Tau和24小时ASPECTS的模型曲线下面积为0.89(95%CI 0.82-0.97;P<0.001),在评估队列(n=66)中维持曲线下面积0.82(95%CI 0.71-0.92;P<0.001)。作者认为入院血浆BD-Tau可准确预测成功血管内治疗后的90天功能结局。
要点
- 入院BD-Tau对90天功能结局的AUC为0.76(95%CI 0.65-0.87;P<0.001)。
- 结合年龄、入院BD-Tau和24小时ASPECTS的模型AUC为0.89(95%CI 0.82-0.97;P<0.001)。
- 该模型在评估队列中AUC为0.82(95%CI 0.71-0.92;P<0.001)。
核心结论
- 入院血浆BD-Tau准确预测大血管闭塞急性缺血性卒中成功血管内治疗后的90天功能结局。
- 所提出的模型可能利用客观指标预测功能结局,减少人为偏倚,并作为急性缺血性卒中的简化预后工具。
研究设计与样本
- 研究纳入两个时间独立的前瞻性队列,均为前循环大血管闭塞急性缺血性卒中且血管内治疗后成功再通的患者。
- 推导队列78例,平均年龄72.9岁,女性占50%;评估队列66例。
- 检测入院时、血管内治疗后即刻、24小时和72小时的血浆BD-Tau、GFAP、NfL和总Tau。
- 24小时神经影像采用Alberta卒中项目早期CT评分(良好结局:>7分或不变),90天功能结局采用改良Rankin量表(有利结局:<3分或不变)。
- 基于推导队列构建多变量逻辑回归模型预测90天功能结局,并在评估队列中评估模型性能。
主要发现
- 推导队列中62%的患者24小时神经影像结局良好,45%的患者90天功能结局有利。
- GFAP从入院至血管内治疗的变化率是早期神经影像结局的最佳预测指标,但对90天功能结局无预测价值。
- 入院时BD-Tau对90天功能结局的区分性能最高,AUC为0.76(95%CI 0.65-0.87;P<0.001)。
- 结合年龄、入院BD-Tau和24小时ASPECTS的模型对90天功能结局区分度极好,AUC为0.89(95%CI 0.82-0.97;P<0.001)。
- 该评分在评估队列中维持预测性能,AUC为0.82(95%CI 0.71-0.92;P<0.001)。
关键数值与推荐
- 良好24小时神经影像结局定义为24小时ASPECTS>7分或不变。
- 有利90天功能结局定义为改良Rankin量表<3分或不变。
- 入院BD-Tau预测90天功能结局的AUC为0.76(95%CI 0.65-0.87;P<0.001)。
- 结合年龄、入院BD-Tau和24小时ASPECTS的模型AUC为0.89(95%CI 0.82-0.97;P<0.001)。
- 评估队列中该模型AUC为0.82(95%CI 0.71-0.92;P<0.001)。
临床怎么用
- 作者认为入院血浆BD-Tau可准确预测大血管闭塞急性缺血性卒中成功血管内治疗后的90天功能结局。
- 作者提出该模型可能利用客观指标预测功能结局,减少人为偏倚,并作为急性缺血性卒中的简化预后工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Large vessel occlusion acute ischemic stroke prognosis improved following the 2015 endovascular therapy (EVT) trials. Blood-based biomarkers may improve outcome prediction. We aimed to assess plasma brain-derived tau (BD-Tau) performance in predicting post-EVT large vessel occlusion acute ischemic stroke outcomes. METHODS: We included 2 temporally independent prospective cohorts of anterior circulation in patients with large vessel occlusion acute ischemic stroke who successfully recanalized post-EVT. We measured plasma BD-Tau, GFAP (glial-fibrillary-acidic-protein), NfL (neurofilament-light-chain), and total-Tau upon admission, immediately, 24 hours, and 72 hours post-EVT. Twenty-four-hour neuroimaging and 90-day functional outcomes were independently assessed using the Alberta Stroke Program Early Computed Tomography Score (good outcome: >7 or unchanged) and the modified Rankin Scale (favorable outcome <3 or unchanged), respectively. Based on the first cohort (derivation), we built a multivariable logistic regression model to predict a 90-day functional outcome. Model results were evaluated using the second cohort (evaluation). RESULTS: In the derivation cohort (n=78, mean age=72.9 years, 50% women), 62% of patients had a good 24-hour neuroimaging outcome, and 45% had a favorable 90-day functional outcome. GFAP admission-to-EVT rate-of-change was the best predictor for early neuroimaging outcome but not for 90-day functional outcome. At admission, BD-Tau levels presented the highest discriminative performance for 90-day functional outcomes (area under the curve, 0.76 [95% CI, 0.65-0.87]; P<0.001). The model incorporating age, admission BD-Tau, and 24-hour Alberta Stroke Program Early Computed Tomography Score achieved excellent discrimination of 90-day functional outcome (area under the curve, 0.89 [95% CI, 0.82-0.97]; P<0.001). The score's predictive performance was maintained in the evaluation cohort (n=66; area under the curve, 0.82 [95% CI, 0.71-0.92]; P<0.001). CONCLUSIONS: Admission plasma BD-Tau accurately predicted 90-day functional outcomes in patients with large vessel occlusion acute ischemic stroke after successful EVT. The proposed model may predict functional outcomes using objective measures, minimizing human-related biases and serving as a simplified prognostic tool for AIS.
引用
- Varela R, Gonzalez-Ortiz F, Dias A, et al. Plasma Brain-Derived Tau in Prognosis of Large Vessel Occlusion Ischemic Stroke. Stroke. 2024. PMID: 39051090. doi:10.1161/STROKEAHA.123.046117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。